Texas Tech University Health Sciences Center
Trial Pipeline
Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction
NCT07451210
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
NCT06903819
L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD
NCT07189442
Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy
NCT06349772
Curcumin and Retinal Study
NCT05774704
Annatto-derived GG for Statin-associated Myopathy
NCT05312424
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
NCT05408559
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
NCT03934905
Prospective Data Bank Creation to Study Vaginal Conditions
NCT01829204
The Maternal Well-Being Study
NCT05484999
Stroboscopic Vision Training in Softball
NCT04309188
Tocotrienols for Obesity of Postmenopausal Women
NCT03705845
Soft Tissue Mobilization for Lumbopelvic Pain in the Third Trimester of Pregnancy
NCT03433404
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
NCT04162262
Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing IVF
NCT02591186
Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors
NCT02938780
Effect of Intranasal Insulin on LH Concentrations in Man
NCT02154477
Observational Study of the Association Between Periodontal Disease and Cardiovascular Disease
NCT02177591
Pain Control With Total Knee Replacement
NCT01680549
Interventional Study of Effects on Spine Height With Two Unloading Positions
NCT01048749
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 4 | 2 |
What the Pipeline for Texas Tech University Health Sciences Center Shows
According to the ClinicalTrials.gov registry, Texas Tech University Health Sciences Center is linked to 20 US clinical trials across every stage of research activity. Of those, 9 studies are currently recruiting — about 45% of the sponsor's indexed portfolio — and 8 are already marked complete, representing roughly 40% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Texas Tech University Health Sciences Center reports 2 late-stage studies (Phase 3 and Phase 4 combined) and 7 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Texas Tech University Health Sciences Center is Low Back Pain with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.